前进一步:T细胞在癌症治疗中重定向双特异性抗体
Xiaojing Qin1,2, Wenjing Ning1,2, Han Liu1,2
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.
Acta pharmaceutica Sinica. B
|June 3, 2024
概括
重定向T细胞双特异性抗体在癌症免疫疗法中表现有前途,通过将T细胞与瘤联系起来以进行向杀死. 本综述探讨了将这种疗法应用于固体瘤的挑战和策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 转向T细胞的双特异性抗体 (TRBs) 通过CD3和瘤相关抗原将T细胞和瘤细胞连接起来.
- TRBs激活T细胞以诱导向瘤细胞溶解,这代表了癌症免疫治疗的重大进展.
- 虽然TRB在血液性恶性瘤中有效,但在固体瘤治疗中面临挑战.
研究的目的:
- 审查阻碍TRBs在固体瘤中的有效性的关键挑战.
- 探索克服这些障碍的新策略.
- 扩大TRB疗法的应用到固体瘤治疗.
主要方法:
- 对癌症免疫治疗中TRBs当前研究的文献综述.
- 分析固体瘤微环境所面临的挑战.
- 讨论 TRB 发展的新兴战略和未来方向.
主要成果:
- TRB已经在血液癌症中取得了成功.
- 在固体瘤中应用TRB仍然存在重大障碍,包括瘤透和抗原异质性.
- 正在开发新的策略,以提高TRB在固体瘤中的疗效.
结论:
- TRBs是一种有前途的免疫疗法,但它们在固体瘤中的潜力在很大程度上尚未开发.
- 克服特定的挑战对于成功转化为固体瘤至关重要.
- 对新策略的持续研究将是扩大TRB疗法用于固体癌症治疗的关键.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891